Also listed under Anemia, Hemolytic, Congenital

Disease landscape

Thalassemia clinical trials

Get alerts when Thalassemia trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

  1. Minor
    2 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-09-02 NCT07799571 Buprenorphine for the Management of Pain in Children With Sickle Cell Disease Natasha Archer new Phase 1
2026-08-31 NCT07796022 Clinical, Economic,and Psychosocial Burden of Thalassemia in Sohag Randa Elham Hamam new
2026-08-24 NCT07782931 Evaluate the Efficacy and Safety of Irochel for the Management of Iron Overload in… Hamdard University new Phase 3
2026-07-23 NCT07721480 Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia Prince of Wales Hospital, Shatin, Hong Kong new Phase 2

Active trials by phase

Early Phase 1
9
Phase 1
11
Phase 1/2
13
Phase 2
23
Phase 3
10
Phase 4
4
Not charted: 62 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Top sponsors by active trials in this area

National Heart, Lung, and Blood Institute (NHLBI) (7) · Agios Pharmaceuticals, Inc. (6) · Assiut University (6) · Bristol-Myers Squibb (6) · CorrectSequence Therapeutics Co., Ltd (4) · Institute of Hematology & Blood Diseases Hospital, China (4) · Shenzhen Hemogen (4) · Bioray Laboratories (3) · First Affiliated Hospital of Guangxi Medical University (3) · Hospital Universitari Vall d'Hebron Research Institute (3)

Get alerts when Thalassemia trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials